Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Operating Income (2017 - 2025)

Catheter Precision (VTAK) has disclosed Operating Income for 9 consecutive years, with -$3.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Income fell 5.67% to -$3.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$14.3 million, a 32.85% decrease, with the full-year FY2024 number at -$11.2 million, up 85.61% from a year prior.
  • Operating Income was -$3.0 million for Q3 2025 at Catheter Precision, up from -$4.7 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$2.6 million in Q4 2023 to a low of -$66.5 million in Q1 2023.
  • A 5-year average of -$8.3 million and a median of -$4.8 million in 2022 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: crashed 1108.14% in 2023, then soared 96.07% in 2024.
  • Catheter Precision's Operating Income stood at -$7.4 million in 2021, then decreased by 10.34% to -$8.2 million in 2022, then skyrocketed by 68.39% to -$2.6 million in 2023, then fell by 17.48% to -$3.1 million in 2024, then increased by 0.98% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Operating Income are -$3.0 million (Q3 2025), -$4.7 million (Q2 2025), and -$3.6 million (Q1 2025).